Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab

BACKGROUND: Dynamic contrast-enhanced ultrasonography (DCE-US) has been used for evaluation of tumor response to antiangiogenic treatments. The objective of this study was to assess the link between DCE-US data obtained during the first week of treatment and subsequent tumor progression. PATIENTS AN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Oncol
Main Authors: Lassau, N., Coiffier, B., Kind, M., Vilgrain, V., Lacroix, J., Cuinet, M., Taieb, S., Aziza, R., Sarran, A., Labbe-Devilliers, C., Gallix, B., Lucidarme, O., Ptak, Y., Rocher, L., Caquot, L. M., Chagnon, S., Marion, D., Luciani, A., Feutray, S., Uzan-Augui, J., Benatsou, B., Bonastre, J., Koscielny, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035788/
https://ncbi.nlm.nih.gov/pubmed/27502701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw280
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados